Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gam-COVID-Vac M in Adolescents
NCT04954092Phase 3Unknown
- Start
- Jul 2021
- Primary completion
- Nov 2022
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Gam-COVID-Vac M in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
Gam-COVID-Vac M
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04954092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04954092.